The Evolving Impact of Myocardial Injury in Patients With COVID-19 Amid the Omicron Wave of the Pandemic.

导出 OA

翻译打印收藏纠错

作者： Brian C,Case ^[1] ; Corey,Shea ^[1] ; Hank,Rappaport ^[1] ; Matteo,Cellamare ^[1] ; Cheng,Zhang ^[1] ; Mason,Zhu ^[1] ; Giorgio A,Medranda ^[1] ; Lowell F,Satler ^[1] ; Itsik,Ben-Dor ^[1] ; Hayder,Hashim ^[1] ; Toby,Rogers ^[2] ; Ron,Waksman ^[3]

作者单位： Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, District of Columbia. ^[1] Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, District of Columbia; Cardiovascular Branch, Division of Intramural Research, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland. ^[2] Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, District of Columbia. Electronic address: ron.waksman@medstar.net. ^[3]

关键词 COVID-19 In-hospital outcomes Myocardial injury Omicron Troponin elevation

主题词人类(Humans);疾病大流行(Pandemics);心脏损伤(Heart Injuries);肌钙蛋白(Troponin)

DOI 10.1016/j.amjcard.2022.11.041

PMID 36563459

发布时间 2023-04-26

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交